Shanghai has emerged as a major hub for CAR-T cell therapy, drawing international patients to the city for the high-end ...

Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a ...

Based on internal projections for demand, the two companies have approved about $150 million in additional investments to ...

During a Case-Based Roundtable® event, Robert Z. Orlowski, MD, PhD, discussed the case of a patient who had progression of multiple myeloma after quadruplet frontline with transplant.

Dr. Joseph Mikhael discusses early signs, treatments and supportive care for multiple myeloma in an interview with CURE.

Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

A multiple myeloma treatment offers hope, but has a high cost. A Houston trial aims to make this life-saving therapy ...

After being diagnosed with multiple myeloma, Valarie Traynham turned her journey into a mission—raising awareness, educating ...

Legend Biotech’s (LEGN) shares have surged over 10% in the past few days, spurred by the company’s latest earnings report, thanks to ...

March has been declared Multiple Myeloma Month in BC following the efforts of an advocacy group in Abbotsford. Multiple ...

Follow along on our guide to Multiple Myeloma, a cancer of the bone marrow's infection-fighting plasma cells. As cancerous ...

Our friend and colleague Kevin Drum passed away on March 7. He was 66 and had been living with multiple myeloma for 11 years, and being the extraordinary journalist he was, he had taken readers along ...